全文获取类型
收费全文 | 210492篇 |
免费 | 50503篇 |
国内免费 | 3293篇 |
专业分类
耳鼻咽喉 | 2407篇 |
儿科学 | 7939篇 |
妇产科学 | 1539篇 |
基础医学 | 37332篇 |
口腔科学 | 7956篇 |
临床医学 | 22459篇 |
内科学 | 43903篇 |
皮肤病学 | 6257篇 |
神经病学 | 24947篇 |
特种医学 | 7376篇 |
外国民族医学 | 15篇 |
外科学 | 21852篇 |
综合类 | 13090篇 |
现状与发展 | 14篇 |
一般理论 | 9篇 |
预防医学 | 15810篇 |
眼科学 | 2889篇 |
药学 | 23869篇 |
36篇 | |
中国医学 | 7853篇 |
肿瘤学 | 16736篇 |
出版年
2024年 | 402篇 |
2023年 | 1870篇 |
2022年 | 3161篇 |
2021年 | 5659篇 |
2020年 | 9616篇 |
2019年 | 15109篇 |
2018年 | 14454篇 |
2017年 | 15393篇 |
2016年 | 14600篇 |
2015年 | 14622篇 |
2014年 | 16856篇 |
2013年 | 18058篇 |
2012年 | 16171篇 |
2011年 | 16813篇 |
2010年 | 14238篇 |
2009年 | 10186篇 |
2008年 | 10530篇 |
2007年 | 8619篇 |
2006年 | 7836篇 |
2005年 | 7117篇 |
2004年 | 6501篇 |
2003年 | 5821篇 |
2002年 | 5238篇 |
2001年 | 4201篇 |
2000年 | 2731篇 |
1999年 | 1565篇 |
1998年 | 1195篇 |
1997年 | 1055篇 |
1996年 | 947篇 |
1995年 | 793篇 |
1994年 | 728篇 |
1993年 | 664篇 |
1992年 | 642篇 |
1991年 | 559篇 |
1990年 | 502篇 |
1989年 | 399篇 |
1988年 | 372篇 |
1987年 | 321篇 |
1986年 | 295篇 |
1985年 | 942篇 |
1984年 | 1132篇 |
1983年 | 892篇 |
1982年 | 1029篇 |
1981年 | 950篇 |
1980年 | 718篇 |
1979年 | 657篇 |
1978年 | 475篇 |
1977年 | 387篇 |
1976年 | 438篇 |
1975年 | 322篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
1.
2.
3.
4.
5.
《The Journal for Nurse Practitioners》2022,18(2):245-247
Transient stress hyperglycemia in the setting of acute myocardial infarction is a frequent phenomenon. Its transient nature should not dissuade the clinician from management of elevated blood glucose in a patient after an ST-elevation myocardial infarction. This case presents an adult patient after an ST-elevation myocardial infarction with transient stress hyperglycemia and the evidence used to identify optimal pharmacologic management and secondary prevention. 相似文献
6.
7.
《Journal of vascular and interventional radiology : JVIR》2022,33(4):399-407
PurposeTo evaluate the midterm outcomes of percutaneous transluminal renal angioplasty (PTRA) for pediatric renovascular hypertension (RVH).Materials and MethodsThe clinical data of patients who underwent PTRA for RVH in the authors’ hospital from 2012 to 2019 were retrospectively analyzed. Postprocedural blood pressure, glomerular filtration rate (GFR) of the affected kidney, restenosis, and complications were closely monitored.ResultsPTRA was performed in a total of 30 children (20 boys and 10 girls), with a mean age of 7.3 years ± 0.7 (range, 40 days to 13.9 years) and a mean weight of 25.0 kg ± 2.3 (range, 3.4–53 kg). The median follow-up period was 26.5 months (range, 1 month to 7.5 years). Technical success was achieved in 26 (86.7%) of the 30 patients. Restenosis developed in 3 patients (10.0%). Only 1 patient underwent stent implantation, and the stent fractured 8 months later, requiring further intervention. There were no other complications. In terms of clinical benefit of blood pressure control after the initial PTRA procedure, 15 patients (50%) were cured and 7 patients (23.3%) showed improvement. There was no significant difference in the etiology, lesion location, and lesion length between patients with clinical benefit and failure (P = .06, P = .202, and P = .06, respectively). GFR of the affected kidney was significantly improved from 19.9 mL/min ± 11.2 to 38.1 mL/min ± 11.9 at the 6-month follow-up after PTRA (P < .001).ConclusionsThe overall results of PTRA for pediatric RVH caused by different etiologies are promising. PTRA not only provided a clinical benefit of blood pressure control in 73.3% of the patients but also significantly improved the function of the affected kidney. 相似文献
8.
Phoebe Hammer Kevin White Stephanie Mengden Vessy Korcheva Philipp W. Raess 《Journal of cutaneous pathology》2019,46(5):343-346
Cutaneous leiomyomas are rare benign smooth‐muscle tumors. These lesions are distinguished based on their cell of origin and are subclassified as pilar leiomyoma, angioleiomyoma, and genital‐type leiomyoma. Nipple leiomyoma is the least common genital‐type leiomyoma, arising from the dartoic muscle cell of the nipple. Histologic examination of the lesion is necessary for definitive diagnosis, and these uncommon tumors can pose a diagnostic challenge. We describe herein a series of six nipple leiomyomas with a spectrum of histologic appearances. 相似文献
9.
Keiko Goto Yutaka Fujiwara Takeshi Isobe Naoko Chayahara Naomi Kiyota Toru Mukohara Yukari Tsubata Takamasa Hotta Kenji Tamura Noboru Yamamoto Hironobu Minami 《Cancer science》2019,110(6):1987-1994
Although dose reduction of S‐1 is recommended for patients with impaired renal function, dose modification for such patients has not been prospectively evaluated. The aim of the present study was to investigate the pharmacokinetic parameters of 5‐fluorouracil, 5‐chloro‐2,4 dihydroxypyridine and oteracil potassium, and to review the recommended dose modification of S‐1 in patients with renal impairment. We classified patients receiving S‐1 into 4 groups according to their renal function, as measured using the Japanese estimated glomerular filtration rate (eGFR) equation. The daily S‐1 dose was adjusted based on the patient's eGFR and body surface area. Blood samples were collected for pharmacokinetic analysis. A total of 33 patients were enrolled and classified into 4 groups as follows: 10 patients in cohort 1 (eGFR ≥ 80 mL/min/1.73 m2), 10 patients in cohort 2 (eGFR = 50‐79 mL/min/1.73 m2), 10 patients in cohort 3 (eGFR = 30‐49 mL/min/1.73 m2), and 3 patients in cohort 4 (eGFR < 30 mL/min/1.73 m2). Those in cohorts 3 and 4 treated with an adjusted dose of S‐1 showed a similar area under the curve for 5‐fluorouracil (941.9 ± 275.6 and 1043.5 ± 224.8 ng/mL, respectively) compared with cohort 2 (1034.9 ± 414.3 ng/mL). Notably, while there was a statistically significant difference between cohort 1 (689.6 ± 208.8 ng/mL) and 2 (P = 0.0474) treated with an equal dose of S‐1, there was no significant difference observed in the toxicity profiles of the cohorts. In conclusion, dose adjustment of S‐1 in patients with impaired renal function using eGFR is appropriate and safe. 相似文献